相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Parkin Regulates Programmed Necrosis and Myocardial Ischemia/Reperfusion Injury by Targeting Cyclophilin-D
Teng Sun et al.
ANTIOXIDANTS & REDOX SIGNALING (2019)
A novel echocardiographic method closely agrees with cardiac magnetic resonance in the assessment of left ventricular function in infarcted mice
Ilaria Russo et al.
SCIENTIFIC REPORTS (2019)
Guidelines for measuring cardiac physiology in mice
Merry L. Lindsey et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2018)
Liraglutide repairs the infarcted heart: The role of the SIRT1/Parkin/mitophagy pathway
Huiying Qiao et al.
MOLECULAR MEDICINE REPORTS (2018)
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial
Adrian F. Hernandez et al.
LANCET (2018)
Delayed therapeutic hypothermia protects against the myocardial no-reflow phenomenon independently of myocardial infarct size in a rat ischemia/reperfusion model
Wangde Dai et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2017)
Lack of effect of prolonged treatment with liraglutide on cardiac remodeling in rats after acute myocardial infarction
Kasper Kyhl et al.
PEPTIDES (2017)
Impaired mitochondrial biogenesis is a common feature to myocardial hypertrophy and end-stage ischemic heart failure
Annalinda Pisano et al.
CARDIOVASCULAR PATHOLOGY (2016)
alpha-MHC MitoTimer mouse: In vivo mitochondrial turnover model reveals remarkable mitochondrial heterogeneity in the heart
Aleksandr Stotland et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2016)
Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
Steven P. Marso et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
Steven P. Marso et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Postinfarct Left Ventricular Remodelling: A Prevailing Cause of Heart Failure
Alessio Galli et al.
CARDIOLOGY RESEARCH AND PRACTICE (2016)
Molecular Characterisation of Small Molecule Agonists Effect on the Human Glucagon Like Peptide-1 Receptor Internalisation
Aiysha Thompson et al.
PLOS ONE (2016)
Exercise Prevents Cardiac Injury and Improves Mitochondrial Biogenesis in Advanced Diabetic Cardiomyopathy with PGC-1 alpha and Akt Activation
Hui Wang et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2015)
How Mitochondrial Dynamism Orchestrates Mitophagy
Orian S. Shirihai et al.
CIRCULATION RESEARCH (2015)
Parkin loss leads to PARIS-dependent declines in mitochondrial mass and respiration
Daniel A. Stevens et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Lipid-induced NOX2 activation inhibits autophagic flux by impairing lysosomal enzyme activity
Bharat Jaishy et al.
JOURNAL OF LIPID RESEARCH (2015)
MitoTimer: a novel protein for monitoring mitochondrial turnover in the heart
Roberta A. Gottlieb et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2015)
Stimulation of glucagon-like peptide-1 receptor through exendin-4 preserves myocardial performance and prevents cardiac remodeling in infarcted myocardium
Megan DeNicola et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2014)
Mitophagy Is Required for Acute Cardioprotection by Simvastatin
Allen M. Andres et al.
ANTIOXIDANTS & REDOX SIGNALING (2014)
Liraglutide for the treatment of type 2 diabetes
D Shyangdan et al.
HEALTH TECHNOLOGY ASSESSMENT (2014)
Angiotensin-Neprilysin Inhibition versus Enalapril in Heart Failure
John J. V. McMurray et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Impaired Autophagy Contributes to Adverse Cardiac Remodeling in Acute Myocardial Infarction
Xiaoqian Wu et al.
PLOS ONE (2014)
MitoTimer A novel tool for monitoring mitochondrial turnover
Genaro Hernandez et al.
AUTOPHAGY (2013)
Do GLP-1-Based Therapies Increase Cancer Risk?
Michael A. Nauck et al.
DIABETES CARE (2013)
Parkin Protein Deficiency Exacerbates Cardiac Injury and Reduces Survival following Myocardial Infarction
Dieter A. Kubli et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Bit-by-bit autophagic removal of parkin-labelled mitochondria
Jin-Yi Yang et al.
NATURE COMMUNICATIONS (2013)
GLP1 and cancer: friend or foe?
Roman Vangoitsenhoven et al.
ENDOCRINE-RELATED CANCER (2012)
New Strategies for Echocardiographic Evaluation of Left Ventricular Function in a Mouse Model of Long-Term Myocardial Infarction
Carolina Benavides-Vallve et al.
PLOS ONE (2012)
Autophagy limits acute myocardial infarction induced by permanent coronary artery occlusion
Hiromitsu Kanamori et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2011)
PARIS (ZNF746) Repression of PGC-1α Contributes to Neurodegeneration in Parkinson's Disease
Joo-Ho Shin et al.
CELL (2011)
Preconditioning Involves Selective Mitophagy Mediated by Parkin and p62/SQSTM1
Chengqun Huang et al.
PLOS ONE (2011)
Executive Summary: Heart Disease and Stroke Statistics-2010 Update A Report From the American Heart Association
Donald Lloyd-Jones et al.
CIRCULATION (2010)
Novel Small Molecule Glucagon-Like Peptide-1 Receptor Agonist Stimulates Insulin Secretion in Rodents and From Human Islets
Kyle W. Sloop et al.
DIABETES (2010)
Insulin-releasing and metabolic effects of small molecule GLP-1 receptor agonist 6,7-dichloro-2-methylsulfonyl-3-N-tert-butylaminoquinoxaline
Nigel Irwin et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2010)
Comparative Effects of the Endogenous Agonist Glucagon-Like Peptide-1 (GLP-1)-(7-36) Amide and the Small-Molecule Ago-Allosteric Agent Compound 2 at the GLP-1 Receptor
Karen Coopman et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
Exenatide Use in the Management of Type 2 Diabetes Mellitus
Angelos Kyriacou et al.
PHARMACEUTICALS (2010)
Beneficial Effects of Mammalian Target of Rapamycin Inhibition on Left Ventricular Remodeling After Myocardial Infarction
Sebastian J. Buss et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Fission and selective fusion govern mitochondrial segregation and elimination by autophagy
Gilad Twig et al.
EMBO JOURNAL (2008)
Small molecule ago-allosteric modulators of the human glucagon-like peptide-1 (hGLP-1) receptor
Min Teng et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
Losartan preserves integrity of cardiac gap junctions and PGC-1α gene expression and prevents cellular apoptosis in remote area of left ventricular myocardium following acute myocardial infarction
Cheuk-Kwan Sun et al.
INTERNATIONAL HEART JOURNAL (2007)
Small-molecule agonists for the glucagon-like peptide 1 receptor
Lotte Bjerre Knudsen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Mechanisms of action of glucagon-like peptide 1 in the pancreas
Maire E. Doyle et al.
PHARMACOLOGY & THERAPEUTICS (2007)
The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes
Daniel J. Drucker et al.
LANCET (2006)
Parkin enhances mitochondrial biogenesis in proliferating cells
Y Kuroda et al.
HUMAN MOLECULAR GENETICS (2006)
Normalization of real-time quantitative reverse transcription-PCR data: A model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets
CL Andersen et al.
CANCER RESEARCH (2004)
Similar elimination rates of glucagon-like peptide-1 in obese type 2 diabetic patients and healthy subjects
T Vilsboll et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Development of heart failure and congenital septal defects in mice lacking endothelial nitric oxide synthase
QP Feng et al.
CIRCULATION (2002)
Echocardiographic evaluation of ventricular remodeling in a mouse model of myocardial infarction
S Kanno et al.
JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY (2002)
The short half-life of glucagon-like peptide-1 in plasma does not reflect its long-lasting beneficial effects
HX Hui et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2002)
分享论文
